Prognosis
Your Organisational Guidance
ebpracticenet urges you to prioritise the following organisational guidance:
Behandeling acuut cardiogeen longoedeem in een urgente situatie (in afwachting van hospitalisatie)Published by: Werkgroep Ontwikkeling Richtlijnen Eerste Lijn (Worel)Last published: 2022La prise en charge de l’oedème pulmonaire aigu cardiogénique en situation d'urgence (en attente d'une hospitalisation)Published by: Groupe de Travail Développement de recommmandations de première ligneLast published: 2022Acute heart failure carries an inpatient mortality of 11% overall; in England and Wales there is significant variation between acute hospitals (lowest 6%; highest 26%).[27]
Predictors of adverse outcomes include: hypotension, renal dysfunction, older age, male sex, ischaemic congestive heart failure (CHF), previous CHF, respiratory rate on admission >30/minute, anaemia, hyponatraemia, elevated troponin, elevated B-type natriuretic peptide, and other comorbidities such as cancer.[83]
The UK National Heart Failure Audit 2023/24 showed that in-patient mortality (10.4%), 30-day mortality (12.5%) and 1-year mortality (30%), were similar to the previous year with a trend towards a consistent reduction in 30-day mortality. Mortality was lower for patients admitted to cardiology (7.21%) compared with general medical (11.3%) wards and for those seen by a specialist (9.27%) compared with those who weren’t (14.03%).[3]
One study found that among patients hospitalised with heart failure, patients across the ejection fraction spectrum have a similarly poor 5-year survival with an elevated risk for cardiovascular and heart failure admission.[84] All patients in this cohort, regardless of ejection fraction, had a remarkably high mortality rate at 5 years from index admission (75.4%).[84]
Use of this content is subject to our disclaimer